7 September 2018
Circassia Pharmaceuticals plc
Notice of Interim Results and Appointment of Broker
Circassia Pharmaceuticals plc (LSE: CIR) announces that it will issue its interim results for the six months ended 30 June 2018 on Thursday 27 September 2018.
Following the results announcement, the Company will hold an analyst meeting at 9.30am at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD. A webcast of the presentation will be available on the Company's website (www.circassia.com).
In addition, Circassia announces that it has appointed Peel Hunt as joint broker to the Company, alongside Numis Securities, with immediate effect.
Enquiries
|
Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications |
Tel: +44 (0)1865 405 560 |
|
Peel Hunt James Steel / Christopher Golden |
Tel: +44 (0) 20 7418 8900 |
|
Numis Securities James Black / Freddie Barnfield |
Tel: +44 (0) 20 7260 1000 |
|
FTI Consulting Simon Conway / Mo Noonan |
Tel: +44 (0) 20 3727 1000 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.